Here's Why You Should Retain Chemed (CHE) Stock for Now [Yahoo! Finance]
Chemed Corp (CHE)
Last chemed corp earnings: 4/28 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.chemed.com/investor-overview
Company Research
Source: Yahoo! Finance
Favorable Hospice industry trends and a strong solvency position are an added advantage. However, macroeconomic headwinds and competitive disadvantages are discouraging for the company. In the past year, this Zacks Rank #3 (Hold) stock has increased 10.1% compared with the 12.2% rise of the industry and a 24.3% rise of the S&P 500 composite. The renowned hospice care provider has a market capitalization of $9.23 billion. In the last reported quarter, the company delivered an average surprise of 5.60%. Let's delve deeper. Upsides VITAS Prospects Bright: Chemed has been registering strong performance from the VITAS business, banking on strength in admissions, which continues to drive higher patient census. The segment's revenues are driven primarily by a rise in the geographically weighted average Medicare reimbursement rate. In the fourth quarter, VITAS' net revenues were up 13.6% year over year. The Average Daily Census, or ADC, expanded by 1,918, an increase of 11% in Q4
Show less
Read more
Impact Snapshot
Event Time:
CHE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CHE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CHE alerts
High impacting Chemed Corp news events
Weekly update
A roundup of the hottest topics
CHE
News
- Chemed Co. (NYSE: CHE) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Chemed (CHE) Lags Q1 Earnings Estimates, Reaffirms 2024 View [Yahoo! Finance]Yahoo! Finance
- Chemed: Q1 Earnings Snapshot [Yahoo! Finance]Yahoo! Finance
- Chemed Reports First-Quarter 2024 Results [Yahoo! Finance]Yahoo! Finance
- Chemed Reports First-Quarter 2024 ResultsBusiness Wire
CHE
Earnings
- 4/24/24 - Beat
CHE
Sec Filings
- 4/29/24 - Form 10-Q
- 4/24/24 - Form 8-K
- 4/17/24 - Form 8-K
- CHE's page on the SEC website